IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BELVISI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.488
NA - Nord America 5.817
AS - Asia 2.834
SA - Sud America 79
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 10
Totale 16.271
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.745
GB - Regno Unito 2.407
IT - Italia 1.595
CN - Cina 1.396
DE - Germania 1.019
SE - Svezia 927
IN - India 380
TR - Turchia 337
IE - Irlanda 261
KR - Corea 214
UA - Ucraina 211
FR - Francia 210
RU - Federazione Russa 168
FI - Finlandia 149
DK - Danimarca 140
HK - Hong Kong 136
NL - Olanda 124
JP - Giappone 122
EU - Europa 94
SG - Singapore 67
CA - Canada 55
BE - Belgio 52
CH - Svizzera 50
CO - Colombia 45
ID - Indonesia 37
GR - Grecia 32
VN - Vietnam 30
IR - Iran 29
ES - Italia 27
PH - Filippine 25
AU - Australia 21
LV - Lettonia 21
TW - Taiwan 20
RO - Romania 19
PL - Polonia 17
BR - Brasile 12
CL - Cile 12
HU - Ungheria 12
MX - Messico 11
NO - Norvegia 10
CZ - Repubblica Ceca 8
PT - Portogallo 8
NZ - Nuova Zelanda 7
AT - Austria 6
PK - Pakistan 6
SC - Seychelles 6
TH - Thailandia 6
UZ - Uzbekistan 6
IL - Israele 5
PY - Paraguay 5
HR - Croazia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
IQ - Iraq 3
QA - Qatar 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CU - Cuba 2
CY - Cipro 2
DM - Dominica 2
EC - Ecuador 2
EE - Estonia 2
JO - Giordania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DZ - Algeria 1
GH - Ghana 1
GT - Guatemala 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NG - Nigeria 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 16.353
Salva come PNG Salva come JPEG
Città #
Southend 2.198
Chandler 893
Milan 664
Seattle 470
Princeton 335
Wilmington 330
Fairfield 316
Beijing 303
Ashburn 295
Ann Arbor 268
Hanover 261
Dublin 260
Woodbridge 193
Mountain View 174
Dearborn 167
Nanjing 163
Houston 161
Phoenix 148
Redmond 125
Munich 117
Jacksonville 114
Redwood City 111
Des Moines 105
Cambridge 101
Bengaluru 88
Hong Kong 85
Shenyang 85
Hangzhou 78
Shanghai 74
Andover 73
Sakarya 68
Boardman 65
Jinan 61
Somerville 60
Medford 59
Eitensheim 52
Brussels 46
Bogotá 45
Mumbai 45
Hebei 44
Serra 44
Istanbul 43
Frankfurt am Main 42
Toronto 42
Changsha 41
Tokyo 39
Berlin 38
Rome 38
Nanchang 37
Guangzhou 36
Tianjin 36
Grafing 34
Bitonto 32
Bühl 30
Ningbo 30
Helsinki 29
Bologna 26
Turin 26
San Diego 24
Kunming 23
New York 23
Athens 22
Saint Petersburg 21
Fremont 20
Zhengzhou 19
Lanzhou 18
Wuhan 18
Central 17
Chicago 16
Como 16
Hamburg 16
Los Angeles 16
Norwalk 16
Pavia 16
Napoli 15
Sunnyvale 15
Haikou 14
London 14
Odernheim 14
Seoul 14
Taizhou 14
Auburn Hills 13
Hefei 13
Jiaxing 13
Kwun Tong 13
Nürnberg 13
Pisa 13
Portage 13
Verona 13
Barcelona 12
Central District 12
Piscataway 12
Taipei 12
Taiyuan 12
Warsaw 12
Washington 12
Boston 11
Bucharest 11
Chengdu 11
Pune 11
Totale 10.576
Salva come PNG Salva come JPEG
Nome #
αvβ3 integrin-targeted peptide/peptidomimetic-drug conjugates: in-depth analysis of the linker technology 517
Side chain effect in the modulation of αvβ3/α5β1 integrin activity via clickable isoxazoline-RGDmimetics: development of molecular delivery systems 366
Crystal structure of human E-cadherin-EC1EC2 in complex with a peptidomimetic competitive inhibitor of cadherin homophilic interaction 283
Fast Cyclization of a Proline-Derived Self-Immolative Spacer Improves the Efficacy of Carbamate Prodrugs 254
Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods 250
New beta-lactam derivatives modulate cell adhesion and signaling mediated by RGD-binding and leukocyte integrins 219
Second generation of Fucose-based DC-SIGN ligands : affinity improvement and specificity versus Langerin 211
Insights into the Binding of Cyclic RGD Peptidomimetics to a5b1 Integrin by using Live-Cell NMR And Computational Studies 203
Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions 197
New SMAC mimetic compounds as apoptosis inducers 192
Tumor targeting with an isoDGR-Drug conjugate 176
Complete characterization of extracts of Onopordum illyricum L (Asteraceae) by HPLC/PDA/ESIMS and NMR 173
Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies 173
Thermodynamically-Weighted Conformational Ensemble of Cyclic RGD Peptidomimetics from NOE Data 171
Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin αVβ3 162
Synthesis of functionalized azabicycloalkane amino acids as dipeptide mimics 160
Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin αVβ3 160
Design and synthesis of peptidomimetic molecules targeting cadherin-mediated protein-protein interactions 159
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate 159
Synthesis, characterization, and biological evaluation of a dual-action ligand targeting αvβ3 integrin and VEGF receptors 157
Modellistica computazionale di peptidomimetici modulatori di interazioni proteina-proteina 156
Synthesis and biological evaluation (in Vitro and in Vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αvβ3 156
β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate 155
Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors 154
Design of SMAC-Diablo Mimics Targeting XIAP/BIR3 Domain for Apoptosis Induction: a Computational Study. 152
A NMR STUDY OF SMAC MIMICS TARGETING BOTH THE BIR2 AND BIR3 DOMAINS IN XIAP PROTEIN. 148
Ciclopepeptidi ibridi contenenti amminoacidi cicloalcanici, e loro preparazione ed uso 146
Functionalized azabicycloalkane amino acids by nitrone 1,3-dipolar intramolecular cycloaddition 146
Stereoselective synthesis of 6,5-bicyclic reverse-turn peptidomimetics 146
A dimeric bicyclic RGD ligand displays enhanced integrin binding affinity and strong biological effects on U-373 MG glioblastoma cells 145
Dual-action ligand targeting both integrin αvβ3 and VEGF receptors 144
RGD-based peptides targheting αIIbβ3 and αvβ3 integrin receptors: an NMR point of view 142
Targeting integrins: Insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids 141
Synthesis and Conformational Analysis of a α-Man-(1→2)-α-Man-(1→6)-α-Man Mimic 141
Cyclic isoDGR peptidomimetics as low-nanomolar αvβ 3 integrin ligands 140
Investigating the Interaction of Cyclic RGD Peptidomimetics with αVβ6 Integrin by Biochemical and Molecular Docking Studies 135
Potent integrin ligands containing a bifunctional diketopiperazine scaffold 133
Synthesis and Conformational Studies of Peptidomimetics Containing a New Bifunctional Diketopiperazine Scaffold Acting as a beta-Hairpin Inducer 130
Nuovi composti antitumorali 130
New homo- and heretodimeric SMAC mimetic compound as apoptosis inducers 130
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II : Structural and biological characterization 130
Synthesis of azabicycloalkane amino acid scaffolds as reverse-turn inducer dipeptide mimics 129
Synthesis of cyclic RGD peptidomimetics, containing a bifunctional diketopiperazine scaffold, as new integrin ligands 128
Cyclic Peptide Integrin Derivatives for Use as Anticancer Agents 128
A combination of Metadynamics and docking calculations rationalizes the effects induced by N-Methylation on RGD-cyclopeptides integrin affinity 126
Targeting protein-protein interactions in cancer with peptidomimetics: insights into ligand conformation and ligand-receptor interactions 125
Analisi NMR delle interazioni tra peptidomimetici e proteine di membrana in cellule intatte 122
Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands 122
Cyclic RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands 121
3D Models of oligopeptides by Molecular Mechanics and Conformational Analysis 120
Design and synthesis of potent integrin ligands containing a bifunctional diketopiperazine scaffold 120
A critical assessment of force field accuracy against NMR data for cyclic peptides containing β-amino acids 120
A Potent Integrin Antagonist from a Small Library of Cyclic RGD Pentapeptide Mimics Including Benzyl-Substituted Azabicycloalkane Amino Acids 119
Binding of RGD-peptide mimics to intact human platelets : an NMR study 118
Targeting integrins alphaVbeta3 and alphaIIbeta3 with RGD peptidomimetics : study of the ligand conformation and of the ligand-receptor interactions 117
Functionalized 2-Hydroxybenzaldehyde-PEG Modules as Portable Tags for the Engagement of Protein Lysine ϵ-Amino Groups 117
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 116
STD and trNOESY NMR Study of Receptor-Ligand Interactions in Living Cancer Cells 116
A Trifunctional Self-Immolative Spacer Enables Drug Release with Two Non-Sequential Enzymatic Cleavages 116
A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein 115
Binding of RGD-Peptide Mimics to Living Human Cancer Cells: a NMR Study 114
Cyclic RGD-Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands 113
Antiangiogenic Effect of Dual/Selective alpha5beta1/alphavbeta3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics. 113
Modelling cadherin-mediated protein-protein interactions by atomistic simulations 112
Applicazioni di modellistica computazionale: molecole, biomolecole e complessi 111
Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma 111
Innovative linker strategies for tumor‐targeted drug conjugates 111
High Affinity vs. Native Fibronectin in the Modulation of αvβ3 Integrin Conformational Dynamics : Insights from Computational Analyses and Implications for Molecular Design 110
A fragment-based virtual screening approach to identify e-cadherin lingands 110
Nonpeptide Integrin Antagonists : RGD Mimetics Incorporating Substituted Azabicycloalkanes as Amino Acid Replacements 110
Synthesis of Gd and [68Ga] complexes in conjugation with a conformationally-optimized RGD sequence as potential MRI and PET tumour-imaging probes 109
Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists 106
Insights into molecular bases of cadherin : small ligands interaction by STD : NMR 106
New potent alpha(v)beta(3) integrin ligands based on azabicycloalkane (gamma,alpha)-dipeptide mimics 106
Synthesis of substituted conformationally constrained 6,5- and 7,5-fused bicyclic lactams as dipeptide mimics 105
CD spectra of Trp-containing peptides in the near-UV: a useful tool to assess peptide conformational stability 105
Design, Synthesis and Biological Evaluation of Novel cRGD-Paclitaxel Conjugates for Integrin-Assisted Drug Delivery 104
Stem-Like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-Cancer Drugs 104
Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I : synthesis 103
Design, synthesis, conformational analysis and application of azabicycloalkane amino acids as constrained dipeptide mimics 102
Targeting Integrin alpha(V)beta(3) with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario 102
CD spectra in the near-UV of VEGF-C analogs to assess peptide conformational stability 101
Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting 100
Stereoselective synthesis of C-alpha-tetrasubstituted azabicyclo[X.3.0]alkane amino acids 100
Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and αIIbβ3 integrin-rich intact cells by NMR and computational studies 100
Different behavior of cyclic RGD peptidomimetics versus a5b1 and aVb3 integrin-rich cancer cells: NMR and computational analysis 100
Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alpha(V)beta(3)/alpha(V)beta(5) integrin dual binders 98
Synthesis of multimeric integrin ligands for the selective tumor-targeted delivery of cytotoxic drugs 98
Synthesis and biological evaluation of new RGD-camptothecin conjugates bearing disulfide linkers 98
Assessing the influence of electrostatic schemes on molecular dynamics simulations of secondary structure forming peptides 97
A new optical imaging probe targeting αVβ3 integrin in glioblastoma xenografts 97
A Comprehensive NMR Analysis of the Interaction between DKP-RGD Ligands and Membrane Proteins on Intact Cells 97
Synthesis and conformational analysis of β-hairpin mimics containing bifunctional diketopiperazine scaffolds 96
Cyclic isoDGR and RGD peptidomimetics: integrin antagonists and tumor-homing devices 96
Transferred-NOE NMR Experiments on Intact Human Platelets: Receptor-Bound Conformation of RGD-Peptide Mimics. 95
Biological and molecular properties of a new alpha(v)beta(3)/alpha(v)beta(5) integrin antagonist 95
Computational techniques predict the effects induced by N-methylation of RGD-cyclopeptides on integrin affinity 94
Conformational analysis of azabicycloalkane amino acid scaffolds as reverse-turn inducer dipeptide mimics 93
Cyclic RGD peptides containing azabicycloalkane reverse-turn mimics 92
Synthesis of 8,5-fused bicyclic lactam by stereo- and regioselective radical cyclization 92
Totale 13.743
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019352 0 0 0 0 0 0 0 0 0 81 152 119
2019/20202.336 234 99 89 180 145 247 271 135 427 302 132 75
2020/20212.027 144 145 184 58 204 129 148 154 232 198 322 109
2021/20222.138 171 89 77 113 188 213 200 148 160 158 184 437
2022/20232.859 360 311 287 273 268 499 53 211 340 57 128 72
2023/20241.348 75 146 133 78 335 150 73 149 63 146 0 0
Totale 17.458